Vascular dysfunction in streptozotocin-induced experimental diabetes strictly depends on insulin deficiency

Journal of Vascular Research

Volumn 48, Issue 4, 2011, Pages 275-284

  Oelze, Matthias ^a   Knorr, Maike ^a   Schuhmacher, Swenja ^a   Heeren, Tjebo ^a   Otto, Christian ^a   Schulz, Eberhard ^a   Reifenberg, Kurt ^a   Wenzel, Philip ^a   Münzel, Thomas ^a   Daiber, Andreas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Diabetes; Endothelial dysfunction; GTP cyclohydrolase I; Insulin; Oxidative stress; Streptozotocin

Indexed keywords

APOCYNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INSULIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INSULIN DEFICIENCY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR DISEASE;

ACETOPHENONES; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; INSULIN; MALE; MYOCARDIUM; NADPH OXIDASE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 79151484305     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000320627     Document Type: Article

References (53)

1. Cugnet-Anceau C, Bauduceau B: Glycaemic control and cardiovascular morbi-mortality: the contribution of the 2008 studies. Ann Endocrinol (Paris) 2009;70:48-54.
2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653. (Pubitemid 41817713)
3. Jay D, Hitomi H, Griendling KK: Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 2006;40:183-192. (Pubitemid 43069343)
4. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002;105:1656-1662. (Pubitemid 34298608)
5. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001;88:E14-E22.
6. Wendt MC, Daiber A, Kleschyov AL, Mulsch A, Sydow K, Schulz E, Chen K, Keaney JF Jr., Lassegue B, Walter U, Griendling KK, Munzel T: Differential effects of diabetes on the expression of the gp91 phox homologues nox1 and nox4. Free Radic Biol Med 2005;39:381-391. (Pubitemid 40910195)
7. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the akt site. J Clin Invest 2001;108:1341-1348. (Pubitemid 33107762)
8. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S: Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 2003;278:22546-22554. (Pubitemid 36830310)
9. Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J: Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol. Diabetes 2002;51:1118-1124. (Pubitemid 34438358)
10. Bindokas VP, Kuznetsov A, Sreenan S, Polonsky KS, Roe MW, Philipson LH: Visualizing superoxide production in normal and diabetic rat islets of langerhans. J Biol Chem 2003;278:9796-9801. (Pubitemid 36800480)
11. Heitzer T, Finckh B, Albers S, Krohn K, Kohlschutter A, Meinertz T: Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001;31:53-61. (Pubitemid 32568424)
12. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22-28. (Pubitemid 26021690)
13. Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH: Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 2007;116:944-953. (Pubitemid 47300919)
14. Whitsett J, Picklo MJ, Sr., Vasquez-Vivar J: 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol 2007;27:2340-2347. (Pubitemid 350203948)
15. Murray-Lyon IM, Eddleston AL, Williams R, Brown M, Hogbin BM, Bennett A, Edwards JC, Taylor KW: Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet 1968;2:895-898.
16. Arison RN, Feudale EL: Induction of renal tumour by streptozotocin in rats. Nature 1967;214:1254-1255.
17. Rakieten N, Rakieten ML, Nadkarni MR: Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963;29:91-98.
18. Like AA, Rossini AA: Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976;193:415-417.
19. Chang KS, Stevens WC: Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol 1992;107:983-990.
20. Taylor PD, Wickenden AD, Mirrlees DJ, Poston L: Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat. Br J Pharmacol 1994;111:42-48. (Pubitemid 24148703)
21. Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ: Accumulation of fructosyllysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans 2003;31:1423-1425. (Pubitemid 38030991)
22. Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, Hofmann SM, Vlassara H, Shi Y: Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003;108:472-478. (Pubitemid 36935542)
23. Capucci MS, Hoffmann ME, De Groot A, Natarajan AT: Streptozotocin-induced toxicity in CHO-9 and V79 cells. Environ Mol Mutagen 1995;26:72-78.
24. Schein PS, O'Connell MJ, Blom J, Hubbard S, Magrath IT, Bergevin P, Wiernik PH, Ziegler JL, DeVita VT: Clinical antitumor activity and toxicity of streptozotocin (NSC-85998). Cancer 1974;34:993-1000.
25. Li X, Chen H, Epstein PN: Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic β-cells. Diabetes 2006;55:1592-1604. (Pubitemid 44324111)
26. Chen H, Li X, Epstein PN: MNSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity. Diabetes 2005;54:1437-1446. (Pubitemid 40586675)
27. Haughton CL, Dillehay DL, Phillips LS: Insulin replacement therapy for the rat model of streptozotocin-induced diabetes mellitus. Lab Anim Sci 1999;49:639-644. (Pubitemid 30036298)
28. Kobayashi T, Kamata K: Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atherosclerosis 2001;155:313-320. (Pubitemid 32209301)
29. Higashi S, Clermont AC, Dhir V, Bursell SE: Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats. Diabetes 1998;47:653-659. (Pubitemid 28160458)
30. Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mulsch A, Munzel T: Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 2004;66:1372-1382. (Pubitemid 39564764)
31. Wenzel P, Schulz E, Oelze M, Muller J, Schuhmacher S, Alhamdani MS, Debrezion J, Hortmann M, Reifenberg K, Fleming I, Munzel T, Daiber A: AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med 2008;45:619-626.
32. Cos P, Rajan P, Vedernikova I, Calomme M, Pieters L, Vlietinck AJ, Augustyns K, Haemers A, Vanden Berghe D: In vitro antioxidant profile of phenolic acid derivatives. Free Radic Res 2002;36:711-716.
33. Daiber A, Oelze M, Sulyok S, Coldewey M, Schulz E, Treiber N, Hink U, Mulsch A, Scharffetter-Kochanek K, Munzel T: Heterozygous deficiency of manganese superoxide dismutase in mice (MN-SOD+/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Mol Pharmacol 2005;68:579-588. (Pubitemid 41206011)
34. Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mulsch A, Li H, Forstermann U, Munzel T: Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 2006;48:677-684. (Pubitemid 44843872)
35. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-1923.
36. Schuhmacher S, Wenzel P, Schulz E, Oelze M, Mang C, Kamuf J, Gori T, Jansen T, Knorr M, Karbach S, Hortmann M, Mathner F, Bhatnagar A, Forstermann U, Li H, Munzel T, Daiber A: Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1. Hypertension 2010;55:897-904.
37. Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, Jefferson A, Goh N, Rockett KA, Channon KM: Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 2003;112:725-735. (Pubitemid 38057713)
38. Schuhmacher S, Schulz E, Oelze M, Konig A, Roegler C, Lange K, Sydow L, Kawamoto T, Wenzel P, Munzel T, Lehmann J, Daiber A: A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena. Br J Pharmacol 2009;158:510-520.
39. Guzik TJ, West NE, Pillai R, Taggart DP, Channon KM: Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 2002;39:1088-1094. (Pubitemid 34620129)
40. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Munzel T, Daiber A: Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem 2007;282:792-799. (Pubitemid 47076617)
41. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
42. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003;111:1201-1209. (Pubitemid 36519937)
43. Meininger CJ, Cai S, Parker JL, Channon KM, Kelly KA, Becker EJ, Wood MK, Wade LA, Wu G: GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats. Faseb J 2004;18:1900-1902. (Pubitemid 39602277)
44. Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, Forstermann U, Munzel T: Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 2008;198:65-76.
45. Schafer A, Flierl U, Vogt C, Menninger S, Tas P, Ertl G, Bauersachs J: Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus. Pharmacol Res 2007;56:217-223. (Pubitemid 47321205)
46. Hink U, Tsilimingas N, Wendt M, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus: therapeutic implications. Treat Endocrinol 2003;2:293-304. (Pubitemid 37075634)
47. Wang S, Xu J, Song P, Wu Y, Zhang J, Chul Choi H, Zou MH: Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension 2008;52:484-490.
48. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL: Activation of NADPH oxidase by age links oxidant stress to altered gene expression via rage. Am J Physiol Endocrinol Metab 2001;280:E685-E694.
49. Baldus S, Koster R, Chumley P, Heitzer T, Rudolph V, Ostad MA, Warnholtz A, Staude HJ, Thuneke F, Koss K, Berger J, Meinertz T, Freeman BA, Munzel T: Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 2005;39:1184-1190.
50. Hopfner RL, Misurski D, Wilson TW, McNeill JR, Gopalakrishnan V: Insulin and vanadate restore decreased plasma endothelin concentrations and exaggerated vascular responses to normal in the streptozotocin diabetic rat. Diabetologia 1998;41:1233-1240. (Pubitemid 28449092)
51. Russ RD, Tobin BW: Pancreatic islet transplantation, but not intensive insulin therapy, corrects the pulmonary vascular complications of streptozotocin diabetes. Can J Physiol Pharmacol 1998;76:407-417. (Pubitemid 28475396)
52. Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, Forstermann U, Munzel T: Mechanisms underlying recoupling of enos by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 2008;198:65-76.
53. Zou MH, Shi C, Cohen RA: High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 2002;51:198-203.